Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Inventory (2022 - 2024)

Historic Inventory for Atara Biotherapeutics (ATRA) over the last 3 years, with Q4 2024 value amounting to $10.7 million.

  • Atara Biotherapeutics' Inventory rose 977.75% to $10.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.7 million, marking a year-over-year increase of 977.75%. This contributed to the annual value of $10.7 million for FY2024, which is 977.75% up from last year.
  • According to the latest figures from Q4 2024, Atara Biotherapeutics' Inventory is $10.7 million, which was up 977.75% from $14.0 million recorded in Q3 2024.
  • Over the past 5 years, Atara Biotherapeutics' Inventory peaked at $18.7 million during Q2 2024, and registered a low of $1.6 million during Q4 2022.
  • Over the past 3 years, Atara Biotherapeutics' median Inventory value was $9.7 million (recorded in 2023), while the average stood at $10.1 million.
  • As far as peak fluctuations go, Atara Biotherapeutics' Inventory soared by 51197.98% in 2023, and later surged by 977.75% in 2024.
  • Atara Biotherapeutics' Inventory (Quarter) stood at $1.6 million in 2022, then surged by 511.98% to $9.7 million in 2023, then grew by 9.78% to $10.7 million in 2024.
  • Its Inventory was $10.7 million in Q4 2024, compared to $14.0 million in Q3 2024 and $18.7 million in Q2 2024.